Notwithstanding many setbacks, quite a few MDM2 inhibitors have now progressed into late-phase medical improvement. New procedures have also been designed to boost the efficacy of MDM2 inhibitors and to mitigate their on-target toxicity. In this critique, we summarize the progress and challenges in the development of the MDM2 focused https://u-7312291345.qodsblog.com/31750932/not-known-factual-statements-about-abbv-744